| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4142473 | Anales de Pediatría | 2010 | 8 Pages |
Abstract
This study demonstrated that there is more rapid control and lower plasma uric acid levels in patients at high risk for tumour lysis syndrome who received rasburicase compared to allopurinol, as well as lower levels of creatinine and a lower percentage of haemodialysis.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
V. Sánchez Tatay, J.D. López Castilla, J.M. Carmona Ponce, J.M. Pérez Hurtado, E. Quiroga Cantero, M. Loscertales Abril,